{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:41:40Z","timestamp":1790836900661,"version":"4.1.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T00:00:00Z","timestamp":1588550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T00:00:00Z","timestamp":1588550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Depression may be associated with reduced monoamine neurotransmission, particularly serotonin and norepinephrine (NE). Reuptake of NE by the norepinephrine transporter (NET) is the primary mechanism by which many of the antidepressants are high-affinity substrates for NET. This study aimed to examine the effect of lentivirus-mediated shRNA targeting NET in locus coeruleus (LC) on depression-like behaviors of rats. We randomly assigned 60 male Wistar rats to 6 experimental groups: (1) Control group: without chronic unpredictable mild stress (CUMS) and without NET-shRNA treatment; (2) shRNA group: without CUMS\u2009+\u2009NET-shRNA; (3) CUMS group: 3-week CUMS without NET-shRNA; (4) CUMS\u2009+\u2009nonsense shRNA group; (5) CUMS\u2009+\u2009amygdala (Amy)-shRNA group; (6) CUMS+ locus coeruleus (LC)-shRNA group. First, recombinant lentiviral vector expressing shRNA (ShRNA-629, ShRNA-330, ShRNA-1222, ShRNA-1146 or ShRNA- negative control) against NET were produced, and their efficiency in knocking down of NET in PC12 cells were assessed by Q-PCR and western blot analysis. Second, shRNA was injected into the rat LC bilaterally to investigate whether it could prevent the depressive-like behavior induced by 3-week CUMS. Third, we tested the depressive-like behavior of the rats in the forced swimming test, the open field test, the sucrose preference test, as well as the body weight gain at the end of the seventh week. Finally, the protein expressions of NET was measured by western blot and the NE levels were measured by high performance liquid chromatography. Q-PCR and western blot showed that the ShRNA-1146 had the best interference efficiency targeting on NET in PC12 cells (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01). Compared to the depression model group, the immobility time in the forced swimming test was significantly reduced (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01), but the sucrose preference and the total scores in the open field test were significantly increased (all <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01) in the group treated with shRNA in LC. Furthermore, compared with the depression model group, NET levels were significantly decreased (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01), but NE levels were significantly increased in the group treated with shRNA in LC (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). Our findings suggest that Lentivirus-mediated shRNA targeting NET in LC downregulated NET both in vitro and in vivo, resulting in a significant decrease in depressive-like behavior of rats.<\/jats:p>","DOI":"10.1038\/s41398-020-0808-8","type":"journal-article","created":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T17:04:26Z","timestamp":1588611866000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Reduction of depression-like behavior in rat model induced by ShRNA targeting norepinephrine transporter in locus coeruleus"],"prefix":"10.1038","volume":"10","author":[{"given":"Xiangdong","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nian","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueli","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyun","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.","family":"Kosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3326-382X","authenticated-orcid":false,"given":"Xiang Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,4]]},"reference":[{"key":"808_CR1","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/S0140-6736(17)32130-X","volume":"390","author":"D Oladimeji","year":"2017","unstructured":"Oladimeji, D. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390, 1260\u20131344 (2017).","journal-title":"Lancet"},{"key":"808_CR2","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.jad.2018.09.067","volume":"243","author":"K Perlman","year":"2019","unstructured":"Perlman, K. et al. A systematic meta-review of predictors of antidepressant treatment outcome in major depressive disorder. J. Affect Disord. 243, 503\u2013515 (2019).","journal-title":"J. Affect Disord."},{"key":"808_CR3","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.pnpbp.2013.04.009","volume":"45","author":"M Hamon","year":"2013","unstructured":"Hamon, M. & Blier, P. Monoamine neurocircuitry in depression and strategies for new treatments. Prog. Neuropsychopharmacol. Biol. Psychiatry 45, 54\u201363 (2013).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"808_CR4","first-page":"9","volume":"7","author":"C Moret","year":"2011","unstructured":"Moret, C. & Briley, M. The importance of norepinephrine in depression. Neuropsychiatr. Dis. Treat. 7, 9\u201313 (2011).","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"808_CR5","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1365-2826.2010.01988.x","volume":"22","author":"K Itoi","year":"2010","unstructured":"Itoi, K. & Sugimoto, N. The brainstem noradrenergic systems in stress, anxiety and depression. J. Neuroendocrinol. 22, 355\u2013361 (2010).","journal-title":"J. Neuroendocrinol."},{"key":"808_CR6","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.4103\/1673-5374.235019","volume":"13","author":"K Seki","year":"2018","unstructured":"Seki, K., Yoshida, S. & Jaiswal, M. K. Molecular mechanism of noradrenaline during the stress-induced major depressive disorder. Neural Regen. Res. 13, 1159\u20131169 (2018).","journal-title":"Neural Regen. Res."},{"key":"808_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.neubiorev.2018.01.012","volume":"87","author":"M Weger","year":"2018","unstructured":"Weger, M. & Sandi, C. High anxiety trait: a vulnerable phenotype for stress-induced depression. Neurosci. Behav. Rev. 87, 27\u201337 (2018).","journal-title":"Neurosci. Behav. Rev."},{"key":"808_CR8","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.neuroscience.2010.03.046","volume":"168","author":"E Carboni","year":"2010","unstructured":"Carboni, E. et al. Prenatal restraint stress: an in vivo microdialysis study on catecholamine release in the rat prefrontal cortex. Neuroscience 168, 156\u2013166 (2010).","journal-title":"Neuroscience"},{"issue":"Suppl 6","key":"808_CR9","first-page":"3","volume":"67","author":"DJ Nutt","year":"2006","unstructured":"Nutt, D. J. The role of dopamine and norepinephrine in depression and antidepressant treatment. J. Clin. Psychiatry 67(Suppl 6), 3\u20138 (2006).","journal-title":"J. Clin. Psychiatry"},{"key":"808_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S0006-3223(98)80007-3","volume":"44","author":"R Yehuda","year":"1998","unstructured":"Yehuda, R. et al. Plasma norepinephrine and 3-methoxy-4-hydroxyphenylglycol concentrations and severity of depression in combat posttraumatic stress disorder and major depressive disorder. Biol. Psychiatry 44, 56\u201363 (1998).","journal-title":"Biol. Psychiatry"},{"key":"808_CR11","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1097\/01.psy.0000173312.90148.97","volume":".67","author":"BT Mausbach","year":"2005","unstructured":"Mausbach, B. T. et al. Depressive symptoms predict norepinephrine response to a psychological stressor task in Alzheimer\u2019s caregivers. Psychosom. Med .67, 638\u2013642 (2005).","journal-title":"Psychosom. Med"},{"issue":"Suppl E1","key":"808_CR12","first-page":"4","volume":"69","author":"DJ Nutt","year":"2008","unstructured":"Nutt, D. J. Relationship of neurotransmitters to the symptoms of major depressive disorder. J. Clin. Psychiatry 69(Suppl E1), 4\u20137 (2008).","journal-title":"J. Clin. Psychiatry"},{"key":"808_CR13","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s00213-001-0926-9","volume":"159","author":"WS Tse","year":"2002","unstructured":"Tse, W. S. & Bond, A. J. Difference in serotonergic and noradrenergic regulation of human social behaviours. Psychopharmacology 159, 216\u2013221 (2002).","journal-title":"Psychopharmacology"},{"key":"808_CR14","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1152\/physrev.1983.63.3.844","volume":"63","author":"SL Foote","year":"1983","unstructured":"Foote, S. L., Bloom, F. E. & Aston-Jones, G. Nucleus locus ceruleus: new evidence of anatomical and physiological specificity. Physiol. Rev. 63, 844\u2013914 (1983).","journal-title":"Physiol. Rev."},{"key":"808_CR15","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/S0924-977X(02)00102-5","volume":"12","author":"WC Drevets","year":"2002","unstructured":"Drevets, W. C., Bogers, W. & Raichle, M. E. Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. Eur. Neuropsychopharmacol. 12, 527\u2013544 (2002).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"808_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0165-0173(03)00143-7","volume":"42","author":"CW Berridge","year":"2003","unstructured":"Berridge, C. W. & Waterhouse, B. D. The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res. Brain Res. Rev. 42, 33\u201384 (2003).","journal-title":"Brain Res. Brain Res. Rev."},{"key":"808_CR17","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1017\/S1461145713001521","volume":"17","author":"H Takano","year":"2014","unstructured":"Takano, H. et al. Norepinephrine transporter occupancy by nortriptyline in patients with depression: a positron emission tomography study with (S,S)-[18F]FMeNER-D2. Int. J. Neuropsychopharmacol. 17, 553\u2013560 (2014).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"808_CR18","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jneuroim.2005.08.007","volume":"170","author":"S Mata","year":"2005","unstructured":"Mata, S., Urbina, M., Manzano, E., Ortiz, T. & Lima, L. Noradrenaline transporter and its turnover rate are decreased in blood lymphocytes of patients with major depression. J. Neuroimmunol. 170, 134\u2013140 (2005).","journal-title":"J. Neuroimmunol."},{"key":"808_CR19","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/j.1755-5949.2010.00217.x","volume":"17","author":"B Dell\u2019Osso","year":"2011","unstructured":"Dell\u2019Osso, B., Palazzo, M. C., Oldani, L. & Altamura, A. C. The noradrenergic action in antidepressant treatments: pharmacological and clinical aspects. CNS Neurosci. Ther. 17, 723\u2013732 (2011).","journal-title":"CNS Neurosci. Ther."},{"key":"808_CR20","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/j.euroneuro.2016.07.005","volume":"26","author":"B Stefanovic","year":"2016","unstructured":"Stefanovic, B. et al. Melatonin mediated antidepressant-like effect in the hippocampus of chronic stress-induced depression rats: Regulating vesicular monoamine transporter 2 and monoamine oxidase A levels. Eur. Neuropsychopharmacol. 26, 1629\u20131637 (2016).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"808_CR21","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.mam.2012.07.002","volume":"34","author":"AB Pramod","year":"2013","unstructured":"Pramod, A. B., Foster, J., Carvelli, L. & Henry, L. K. SLC6 transporters: structure, function, regulation, disease association and therapeutics. Mol. Asp. Med. 34, 197\u2013219 (2013).","journal-title":"Mol. Asp. Med."},{"key":"808_CR22","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S0006-3223(03)00676-0","volume":"55","author":"S Benmansour","year":"2004","unstructured":"Benmansour, S. et al. Regulation of the norepinephrine transporter by chronic administration of antidepressants. Biol. Psychiatry 55, 313\u2013316 (2004).","journal-title":"Biol. Psychiatry"},{"key":"808_CR23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0197-0186(00)00043-7","volume":"38","author":"C H\u00e9bert","year":"2001","unstructured":"H\u00e9bert, C., Habimana, A., Elie, R. & Reader, T. A. Effects of chronic antidepressant treatments on 5-HT and NA transporters in rat brain: an autoradiographic study. Neurochem. Int. 38, 63\u201374 (2001).","journal-title":"Neurochem. Int."},{"key":"808_CR24","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.biopsych.2007.03.027","volume":"62","author":"GI Papakostas","year":"2007","unstructured":"Papakostas, G. I., Thase, M. E., Fava, M., Nelson, J. C. & Shelton, R. C. Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents. Biol. Psychiatry 62, 1217\u20131227 (2007).","journal-title":"Biol. Psychiatry"},{"key":"808_CR25","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","volume":"163","author":"AJ Rush","year":"2006","unstructured":"Rush, A. J. et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am. J. Psychiatry 163, 1905\u20131917 (2006).","journal-title":"Am. J. Psychiatry"},{"key":"808_CR26","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1056\/NEJMoa052964","volume":"354","author":"MH Trivedi","year":"2006","unstructured":"Trivedi, M. H. et al. Medication augmentation after the failure of SSRIs for depression. N. Engl. J. Med. 354, 1243\u20131252 (2006).","journal-title":"N. Engl. J. Med."},{"key":"808_CR27","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nbt.1769","volume":"29","author":"C Sheridan","year":"2011","unstructured":"Sheridan, C. Gene therapy finds its niche. Nat. Biotechnol. 29, 121\u2013128 (2011).","journal-title":"Nat. Biotechnol."},{"key":"808_CR28","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.neurol.2014.09.004","volume":"170","author":"C Serguera","year":"2014","unstructured":"Serguera, C. & Bemelmans, A. P. Gene therapy of the central nervous system: general considerations on viral vectors for gene transfer into the brain. Rev. Neurol. 170, 727\u2013738 (2014).","journal-title":"Rev. Neurol."},{"key":"808_CR29","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neuropharm.2016.02.013","volume":"120","author":"SR Choudhury","year":"2017","unstructured":"Choudhury, S. R. et al. Viral vectors for therapy of neurologic diseases. Neuropharmacology 120, 63\u201380 (2017).","journal-title":"Neuropharmacology"},{"key":"808_CR30","doi-asserted-by":"publisher","DOI":"10.1017\/erm.2015.6","volume":"17","author":"MJ Kelly","year":"2015","unstructured":"Kelly, M. J., O\u2019Keeffe, G. W. & Sullivan, A. M. Viral vector delivery of neurotrophic factors for Parkinson\u2019s disease therapy. Expert Rev. Mol. Med. 17, e8 (2015).","journal-title":"Expert Rev. Mol. Med."},{"key":"808_CR31","first-page":"159","volume":"31","author":"N Merienne","year":"2015","unstructured":"Merienne, N. & D\u00e9glon, N. Gene silencing approaches for the treatment of Huntington\u2019s disease. Med. Sci. 31, 159\u2013167 (2015).","journal-title":"Med. Sci."},{"key":"808_CR32","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/nrneurol.2015.170","volume":"11","author":"H Malkki","year":"2015","unstructured":"Malkki, H. Alzheimer disease: NGF gene therapy activates neurons in the AD patient brain. Nat. Rev. Neurol. 11, 548 (2015).","journal-title":"Nat. Rev. Neurol."},{"key":"808_CR33","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/S0140-6736(16)30374-9","volume":"388","author":"M Sessa","year":"2016","unstructured":"Sessa, M. et al. Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1\/2 trial. Lancet 388, 476\u2013487 (2016).","journal-title":"Lancet"},{"key":"808_CR34","doi-asserted-by":"publisher","first-page":"54ra76","DOI":"10.1126\/scitranslmed.3001079","volume":"2","author":"B Alexander","year":"2010","unstructured":"Alexander, B. et al. Reversal of depressed behaviors in mice by p11 gene therapy in the nucleus accumbens. Sci. Transl. Med. 2, 54ra76 (2010).","journal-title":"Sci. Transl. Med."},{"key":"808_CR35","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/978-1-62703-311-4_4","volume":"986","author":"S Petri","year":"2013","unstructured":"Petri, S. & Meister, G. siRNA design principles and off-target effects. Methods Mol. Biol. 986, 59\u201371 (2013).","journal-title":"Methods Mol. Biol."},{"key":"808_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-07407-1","volume":"7","author":"T Yan","year":"2017","unstructured":"Yan, T. et al. Antidepressant-like effects and cognitive enhancement of Schisandra chinensis in chronic unpredictable mild stress mice and its related mechanism. Sci. Rep. 7, 6903 (2017).","journal-title":"Sci. Rep."},{"key":"808_CR37","first-page":"331","volume":"79","author":"WA Carlezon","year":"2003","unstructured":"Carlezon, W. A. & Neve, R. L. Viral-mediated gene transfer to study the behavioral correlates of CREB function in the nucleus accumbens of rats. Methods Mol. Med. 79, 331\u2013350 (2003).","journal-title":"Methods Mol. Med."},{"key":"808_CR38","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1126\/science.282.5397.2272","volume":"282","author":"WA Carlezon","year":"1998","unstructured":"Carlezon, W. A. et al. Regulation of cocaine reward by CREB. Science 282, 2272\u20132275 (1998).","journal-title":"Science"},{"key":"808_CR39","doi-asserted-by":"publisher","first-page":"10302","DOI":"10.1523\/JNEUROSCI.22-23-10302.2002","volume":"22","author":"M Azzouz","year":"2002","unstructured":"Azzouz, M. et al. Multicistronic lentiviral vector-mediated striatal gene transfer of aromatic L-amino acid decarboxylase, tyrosine hydroxylase, and GTP cyclohydrolase I induces sustained transgene expression, dopamine production, and functional improvement in a rat model of Parkinson\u2019s disease. J. Neurosci. 22, 10302\u201310312 (2002).","journal-title":"J. Neurosci."},{"key":"808_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/srep16751","volume":"5","author":"G Zhang","year":"2015","unstructured":"Zhang, G. et al. Combined use of spatial restraint stress and middle cerebral artery occlusion is a novel model of post-stroke depression in mice. Sci. Rep. 5, 16751 (2015).","journal-title":"Sci. Rep."},{"key":"808_CR41","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00213-013-3024-x","volume":"228","author":"V Gigliucci","year":"2013","unstructured":"Gigliucci, V. et al. Ketamine elicits sustained antidepressant-like activity via a serotonin-dependent mechanism. Psychopharmacology 228, 157\u2013166 (2013).","journal-title":"Psychopharmacology"},{"key":"808_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/srep35239","volume":"6","author":"JL Yang","year":"2016","unstructured":"Yang, J. L. et al. The effects of high-fat-diet combined with chronic unpredictable mild stress on depression-like behavior and Leptin\/LepRb in male rats. Sci. Rep. 6, 35239 (2016).","journal-title":"Sci. Rep."},{"key":"808_CR43","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.neuroscience.2011.07.005","volume":"192","author":"Y Fan","year":"2011","unstructured":"Fan, Y. et al. Transcription factor Phox2 upregulates expression of norepinephrine transporter and dopamine \u03b2-hydroxylase in adult rat brains. Neuroscience 192, 37\u201353 (2011).","journal-title":"Neuroscience"},{"key":"808_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/srep08890","volume":"5","author":"J Zhao","year":"2015","unstructured":"Zhao, J. et al. Metabolomic identification of biochemical changes induced by fluoxetine and imipramine in a chronic mild stress mouse model of depression. Sci. Rep. 5, 8890 (2015).","journal-title":"Sci. Rep."},{"key":"808_CR45","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1089\/hgtb.2017.079","volume":"28","author":"AL Askou","year":"2017","unstructured":"Askou, A. L. et al. Suppression of choroidal neovascularization in mice by subretinal delivery of multigenic lentiviral vectors encoding anti-angiogenic microRNAs. Hum. Gene Ther. Methods 28, 222\u2013233 (2017).","journal-title":"Hum. Gene Ther. Methods"},{"key":"808_CR46","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/01.sap.0000168211.76318.fa","volume":"55","author":"LX Man","year":"2005","unstructured":"Man, L. X. et al. Lentiviral gene therapy with platelet-derived growth factor B sustains accelerated healing of diabetic wounds over time. Ann. Plast. Surg. 55, 81\u201386 (2005).","journal-title":"Ann. Plast. Surg."},{"key":"808_CR47","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ymthe.2005.02.022","volume":"12","author":"E Shai","year":"2005","unstructured":"Shai, E. et al. Prolonged transgene expression in murine salivary glands following non-primate lentiviral vector transduction. Mol. Ther. 12, 137\u2013143 (2005).","journal-title":"Mol. Ther."},{"key":"808_CR48","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12906-015-0778-1","volume":"15","author":"M Tang","year":"2015","unstructured":"Tang, M. et al. Fish oil supplementation alleviates depressant-like behaviors and modulates lipid profiles in rats exposed to chronic unpredictable mild stress. BMC Complement Altern. Med. 15, 239 (2015).","journal-title":"BMC Complement Altern. Med."},{"key":"808_CR49","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0896-6273(02)00653-0","volume":"34","author":"EJ Nestler","year":"2002","unstructured":"Nestler, E. J. et al. Neurobiology of depression. Neuron 34, 13\u201325 (2002).","journal-title":"Neuron"},{"key":"808_CR50","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/S0140-6736(13)61939-X","volume":"383","author":"S Palfi","year":"2014","unstructured":"Palfi, S. et al. Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson\u2019s disease: a dose escalation, open-label, phase 1\/2 trial. Lancet 383, 1138\u20131146 (2014).","journal-title":"Lancet"},{"key":"808_CR51","doi-asserted-by":"publisher","first-page":"474","DOI":"10.2174\/156652308786848049","volume":"8","author":"A Schambach","year":"2008","unstructured":"Schambach, A. & Baum, C. Clinical application of lentiviral vectors - concepts and practice. Curr. Gene Ther. 8, 474\u2013482 (2008).","journal-title":"Curr. Gene Ther."},{"key":"808_CR52","doi-asserted-by":"publisher","first-page":"53","DOI":"10.9758\/cpn.2015.13.1.53","volume":"13","author":"AB Singh","year":"2015","unstructured":"Singh, A. B., Bousman, C. A., Ng, C. H., Byron, K. & Berk, M. Effects of persisting emotional impact from child abuse and norepinephrine transporter genetic variation on antidepressant efficacy in major depression: a pilot study. Clin. Psychopharmacol. Neurosci. 13, 53\u201361 (2015).","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"808_CR53","first-page":"18837","volume":"8","author":"Y Pan","year":"2015","unstructured":"Pan, Y., Cheng, Q., Shan, M. S. & Yan, J. Association between polymorphism of the norepinephrine transporter gene rs2242446 and rs5669 loci and depression disorders. Int J. Clin. Exp. Med. 8, 18837\u201318842 (2015).","journal-title":"Int J. Clin. Exp. Med."},{"key":"808_CR54","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jpsychires.2014.11.017","volume":"61","author":"YW Yeh","year":"2015","unstructured":"Yeh, Y. W. et al. SLC6A2 variants may predict remission from major depression after venlafaxine treatment in Han Chinese population. J. Psychiatr. Res. 61, 33\u201339 (2015).","journal-title":"J. Psychiatr. Res."},{"key":"808_CR55","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jad.2013.03.016","volume":"150","author":"X Zhao","year":"2013","unstructured":"Zhao, X. et al. Association between major depressive disorder and the norepinephrine transporter polymorphisms T-182C and G1287A: a meta-analysis. J. Affect Disord. 150, 23\u201328 (2013).","journal-title":"J. Affect Disord."},{"key":"808_CR56","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.neulet.2013.12.035","volume":"561","author":"Y Zhou","year":"2014","unstructured":"Zhou, Y., Su, H., Song, J., Guo, L. & Sun, Y. Association between norepinephrine transporter T-182C polymorphism and major depressive disorder: a meta-analysis. Neurosci. Lett. 561, 64\u201368 (2014).","journal-title":"Neurosci. Lett."},{"key":"808_CR57","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ynstr.2016.08.002","volume":"6","author":"P Willner","year":"2017","unstructured":"Willner, P. The chronic mild stress (CMS) model of depression: History, evaluation and usage. Neurobiol. Stress 6, 78\u201393 (2017).","journal-title":"Neurobiol. Stress"},{"key":"808_CR58","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/nprot.2012.044","volume":"7","author":"DA Slattery","year":"2012","unstructured":"Slattery, D. A. & Cryan, J. F. Using the rat forced swim test to assess antidepressant-like activity in rodents. Nat. Protoc. 7, 1009\u20131014 (2012).","journal-title":"Nat. Protoc."},{"key":"808_CR59","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/BF00187257","volume":"93","author":"P Willner","year":"1987","unstructured":"Willner, P., Towell, A., Sampson, D., Sophokleous, S. & Muscat, R. Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacol. 93, 358\u2013364 (1987).","journal-title":"Psychopharmacol."},{"key":"808_CR60","first-page":"761","volume":"290","author":"FA Paczkowski","year":"1999","unstructured":"Paczkowski, F. A., Bryan-Lluka, L. J., P\u00f6rzgen, P., Br\u00fcss, M. & B\u00f6nisch, H. Comparison of the pharmacological properties of cloned rat, human, and bovine norepinephrine transporters. J. Pharm. Exp. Ther. 290, 761\u2013767 (1999).","journal-title":"J. Pharm. Exp. Ther."},{"key":"808_CR61","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/FBP.0b013e32830cd80f","volume":"19","author":"MT Perona","year":"2008","unstructured":"Perona, M. T. et al. Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions. Behav. Pharm. 19, 566\u2013574 (2008).","journal-title":"Behav. Pharm."},{"key":"808_CR62","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.brainres.2014.10.055","volume":"1594","author":"J Solich","year":"2015","unstructured":"Solich, J. et al. Norepinephrine transporter knock-out alters expression of the genes connected with antidepressant drugs action. Brain Res. 1594, 284\u2013292 (2015).","journal-title":"Brain Res."},{"key":"808_CR63","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1471-4159.2009.06345.x","volume":"111","author":"B Haenisch","year":"2009","unstructured":"Haenisch, B., Bilkei-Gorzo, A., Caron, M. G. & B\u00f6nisch, H. Knockout of the norepinephrine transporter and pharmacologically diverse antidepressants prevent behavioral and brain neurotrophin alterations in two chronic stress models of depression. J. Neurochem. 111, 403\u2013416 (2009).","journal-title":"J. Neurochem."},{"key":"808_CR64","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1212\/WNL.0b013e3181c2937c","volume":"73","author":"EE Benarroch","year":"2009","unstructured":"Benarroch, E. E. The locus ceruleus norepinephrine system: functional organization and potential clinical significance. Neurology 73, 1699\u20131704 (2009).","journal-title":"Neurology"},{"key":"808_CR65","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.neuroscience.2012.10.035","volume":"228","author":"J Zhang","year":"2013","unstructured":"Zhang, J., Muller, J. F. & McDonald, A. J. Noradrenergic innervation of pyramidal cells in the rat basolateral amygdala. Neuroscience 228, 395\u2013408 (2013).","journal-title":"Neuroscience"},{"key":"808_CR66","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1017\/S1461145713000370","volume":"16","author":"D De Bundel","year":"2013","unstructured":"De Bundel, D. et al. Hippocampal and prefrontal dopamine D1\/5 receptor involvement in the memory-enhancing effect of reboxetine. Int J. Neuropsychopharmacol. 16, 2041\u20132051 (2013).","journal-title":"Int J. Neuropsychopharmacol."},{"key":"808_CR67","doi-asserted-by":"publisher","first-page":"7888","DOI":"10.1523\/JNEUROSCI.1506-04.2004","volume":"24","author":"ES Vizi","year":"2004","unstructured":"Vizi, E. S., Zsilla, G., Caron, M. G. & Kiss, J. P. Uptake and release of norepinephrine by serotonergic terminals in norepinephrine transporter knock-out mice: implications for the action of selective serotonin reuptake inhibitors. J. Neurosci. 24, 7888\u20137894 (2004).","journal-title":"J. Neurosci."},{"key":"808_CR68","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1523\/JNEUROSCI.22-02-00389.2002","volume":"22","author":"JA Mor\u00f3n","year":"2002","unstructured":"Mor\u00f3n, J. A., Brockington, A., Wise, R. A., Rocha, B. A. & Hope, B. T. Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines. J. Neurosci. 22, 389\u2013395 (2002).","journal-title":"J. Neurosci."},{"key":"808_CR69","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1111\/gbb.12084","volume":"12","author":"HM Fentress","year":"2013","unstructured":"Fentress, H. M. et al. Norepinephrine transporter heterozygous knockout mice exhibit altered transport and behavior. Genes Brain Behav. 12, 749\u2013759 (2013).","journal-title":"Genes Brain Behav."},{"key":"808_CR70","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","volume":"391","author":"A Cipriani","year":"2018","unstructured":"Cipriani, A. et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet 391, 1357\u20131366 (2018).","journal-title":"Lancet"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-020-0808-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-020-0808-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-020-0808-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T14:42:57Z","timestamp":1670251377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-020-0808-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,4]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["808"],"URL":"https:\/\/doi.org\/10.1038\/s41398-020-0808-8","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,4]]},"assertion":[{"value":"20 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"130"}}